PDCD1 and neoplasm: In a report by Seban and colleagues based on 55 melanoma patients treated with anti-PD-1, a high metabolic tumor volume, an increased spleen-to-liver uptake, and bone marrow-to-liver uptake ratio were predictors of survival in multivariate analysis [93].